期刊文献+

恶性肿瘤免疫逃逸与免疫治疗策略 被引量:5

The mechanisms of tumor immune escape and the strategies of clinical treatment
原文传递
导出
摘要 肿瘤具有免疫原性,在人类肿瘤组织中可发现大量肿瘤浸润性淋巴细胞;大多数肿瘤患者在接受主动免疫治疗后可以检测到参与应答反应的肿瘤抗原特异性T细胞.但是主动免疫治疗并未给患者带来显著的临床疗效,究其原因发现肿瘤微环境中的免疫抑制状态削弱了效应细胞的杀瘤活性.因此深入研究肿瘤与免疫系统的相互作用将有助于提高临床生物治疗的疗效. Tumor infiltrating lymphocytes can be found in human tumor tissues.Although after active immune therapy,tumor-reactive T cells could be detected in most patients' peripheral blood,patients often get little clinical benefit.Now it is believed that tumor microenvironment suppresses immune response and causes tumor immune escape.Here we review the mechanism of tumor immune escape and tumor immunotherapy strategies.
出处 《国际免疫学杂志》 CAS 2015年第3期280-283,292,共5页 International Journal of Immunology
关键词 肿瘤微环境 免疫逃逸 免疫疗法 晚期癌症 Tumor microenvironment Iimmune escape Immunotherapy Advanced cancer
  • 相关文献

参考文献21

  • 1Thatcher N, Heighway 1. Maintenance and consolidation therapy in patients with unresectable stage IIIIIV non-small cell lung caneer[J]. Oncologist, 2010,15(10) :1034-1042. 被引量:1
  • 2Franciszkiewicz K, Boissonnas A, Boutet M, et al. Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response[J]. Cancer Res, 20 12, 72 ( 24 ) : 6325-6332. 被引量:1
  • 3Yaguchi T, Sumimoto H, Kudo-Saito C, et al. The mechanisms of cancer immunoescape and development of overcoming strategies[J]. IntJ Hematol,2011 , 93 (3) :294-300. 被引量:1
  • 4AntonyPA, RestifoNP. CD4+ CD25 + Tregulatorycells, immunotherapy of cancer, and interleukin-2[J].J Immunother, 2005, 28 (2) : l20-l28. 被引量:1
  • 5Sharma P,Wagner K, WolchokJD, et al. Novel cancer immunotherapy agents with survival benefit: recent successes and next steps[J]. Nat Rev Cancer, 2011, 11 (11) : 805-812. 被引量:1
  • 6WolchokJD, Neyns B, Linette G, et al. Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study[J] . Lancet Oneol ,2010 , 11 (2) : 155-164. 被引量:1
  • 7BrahmerJR, Tykodi SS, Chow LQ, et al. Safety and activity of anti-PD-Ll antibody in patients with advanced cancer[J]. N EnglJ Med,2012, 366(26) :2455-2465. 被引量:1
  • 8Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma[J]. Curt Opin Immunol,2009, 21(2): 233-240. 被引量:1
  • 9Rosenberg SA, YangJC, Sherry RM, et al. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy[J]. Clin Cancer Res, 2011 , 17 ( \3) : 4550-4457. 被引量:1
  • 10Tran E, Turcotte S, Gras A, et al. Cancer immunotherapy based on mutation-specific CD4 + T cells in a patient with epithelial cancer[J]. Science, 2014, 344(6184) :641-645. 被引量:1

同被引文献31

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部